Data released at EASD 2026 suggests that oral semaglutide may help maintain weight-loss progress while offering a more convenient treatment option, although longer-term outcomes remain to be established. Image credit: Shutterstock/[KK Stock]

Unlock FREE Access to Premium Content

​Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation.

With a free Clinical Trials Arena profile, you can:

  • Access exclusive analyst commentary and expert insights
  • View premium forecasts and data-driven clinical trial intelligence
  • Stay up to date with clinical trial news, regulatory updates, and industry trends
  • Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here

Powered by